What is the distinction between FDA approval and a health claim?
It is critical to distinguish between the FDA's approval of a drug and its authorization of a health claim for a food ingredient. The FDA approves new pharmaceutical drugs after rigorous testing for safety and efficacy. Dietary supplements and food ingredients are not approved in the same way before being sold; they are regulated post-market.
A health claim, like the one for beta glucan, is a statement allowed on food labels that describes a relationship between a food substance and reduced risk of a disease. The FDA authorizes these claims based on scientific evidence, but it is not drug approval. Manufacturers are responsible for the truthfulness of these claims.
The FDA's health claim for beta glucan and heart disease
The FDA authorized a heart-healthy claim for oat beta-glucan in 1997, later including barley in 2005. This allows foods with a specific amount of beta-glucan to claim they help reduce coronary heart disease risk as part of a healthy diet. To use this claim, a food must contain at least 0.75 grams of beta-glucan soluble fiber per serving from qualifying sources like whole oats or barley. The FDA has determined that a daily intake of 3 grams can help lower cholesterol.
Beta glucan's regulatory status as Generally Recognized as Safe (GRAS)
Many beta glucan sources have Generally Recognized as Safe (GRAS) status, an exception to pre-market approval for food additives. GRAS status can be achieved through scientific procedures or common use before 1958.
- Self-Affirmed GRAS: An independent panel deems an ingredient safe.
- FDA-Notified GRAS: A company submits its GRAS data to the FDA, which may issue a 'no questions' letter.
Sources like oats, barley, and yeast beta glucan have achieved GRAS status, confirming their safety as ingredients but not drug-like efficacy.
Comparing FDA regulation of drugs vs. supplements and food ingredients
| Feature | FDA-Approved Drug | FDA-Regulated Supplement/Food Ingredient |
|---|---|---|
| Approval Process | Mandatory pre-market approval with extensive trials. | No pre-market 'approval'; manufacturer ensures safety and labeling. |
| Burden of Proof | Manufacturer must prove effectiveness and safety before market. | Manufacturer must have evidence for claims, but doesn't need prior FDA submission unless it's a 'new dietary ingredient'. |
| Regulatory Approach | Pre-market control. | Post-market oversight for unsafe or misbranded products. |
| Health Claims | Tied to approved medical use. | Authorized for food substances; cannot claim to treat, diagnose, or cure. |
The future of beta glucan and FDA oversight
As research into beta glucan's benefits grows, new regulatory questions may arise. The current health claim is heart-focused; new claims would need additional evidence and review. The form and source of beta glucan also matter. Manufacturers must continue to ensure safety and compliance through GRAS or other means as they develop new products. Consumers can look for products with GRAS status and FDA-authorized health claims for assurance of safety and accurate labeling.
Conclusion
Beta glucan is not 'FDA approved' as a drug but is regulated as a food ingredient or supplement. The FDA has authorized a health claim for beta glucan from certain oats and barley, linking it to cholesterol reduction and reduced heart disease risk. Many forms also have GRAS status, confirming their safety. This framework requires manufacturers to substantiate claims and ensures product safety without drug-like pre-market approval.
Note: This article is for informational purposes only and is not medical advice. Consult with a healthcare professional before starting any new dietary supplement regimen.